Double Immunosuppression With or Without Anti-fibrotic in Scleroderma ILD

Recruiting now

Conditions studied: SSc-Systemic Sclerosis

In brief

Patients with ssc-ild receiving double immunosuppression with or without anti fibrotic tratment

Key facts

Study ID

NCT07491523

Run by

University of Patras

People needed

35

Starts

2025-06-01

Expected to finish

2027-03-01

Last updated by the study team

2026-03-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• ssc without ild

Where it is running

• University of patras — Pátrai, Greece (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.